Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_assertion type Assertion NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_head.
- NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_assertion description "[p57KIP2 was weakly expressed in 4/6 glioblastoma (GBM) specimens by western blot/immunoreactivity was positive in 8/40 GBMs, and was primarily nuclear in location/motility of glioma cells was significantly reduced after p57KIP2 induction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_provenance.
- NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_assertion evidence source_evidence_literature NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_provenance.
- NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_assertion SIO_000772 15332324 NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_provenance.
- NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_assertion wasDerivedFrom lhgdn-20090331 NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_provenance.
- NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_assertion wasGeneratedBy ECO_0000203 NP206582.RAt9S_TmtD0MqycHakWOTDSVcE3YgzWhVPmG4foPlEMrA130_provenance.